Park Ha Biological COO reports 187,500 shares

Park Ha Biological Technology Co., Ltd. reported the initial holdings of its COO, Wang Li (Alya), in a Form 3.

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. reported the initial holdings of its COO, Wang Li (Alya), in a Form 3. She beneficially owns 187,500 Class A Ordinary Shares, held directly. These shares were purchased under the company’s 2026 Share Incentive Plan and the reported amount reflects a 1-for-8 reverse stock split effected on August 6, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wang Li (Alya)

Role COO

Type	Security	Shares	Price	Value
holding	Class A Ordinary Shares F1, F2	--	--	--

Holdings After Transaction: Class A Ordinary Shares — 187,500 shares (Direct)

Footnotes (2)

1. F1. Purchase of Class A ordinary shares from Park Ha Biological Technology Co., Ltd. pursuant to its 2026 Share Incentive Plan.
2. F2. On August 6, 2026, Park Ha Biological Technology Co., Ltd. effected a 1-for-8 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Key Figures

Class A Ordinary Shares owned: 187,500 shares Reverse stock split ratio: 1-for-8 Transaction/holding date: 2026-08-03

3 metrics

Class A Ordinary Shares owned 187,500 shares Shares beneficially owned directly by COO Wang Li (Alya) after reported event

Reverse stock split ratio 1-for-8 Reverse stock split effected on August 6, 2026; holdings adjusted to reflect this

Transaction/holding date 2026-08-03 Date associated with the reported Class A Ordinary Shares holding entry

Key Terms

reverse stock split, Share Incentive Plan, Class A Ordinary Shares

3 terms

reverse stock split financial

"effected a 1-for-8 reverse stock split (the Reverse Stock Split)"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

Share Incentive Plan financial

"pursuant to its 2026 Share Incentive Plan"

A share incentive plan is a company program that gives employees or directors the chance to receive or buy company shares, often after staying with the firm or meeting performance goals. It matters to investors because it’s like giving workers a slice of the company pie to boost performance and loyalty, but issuing those slices can reduce each existing owner’s portion and change metrics such as earnings per share and share count.

Class A Ordinary Shares financial

"Purchase of Class A ordinary shares from Park Ha Biological"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider ownership did BYAH COO Wang Li (Alya) report on this Form 3?

Wang Li (Alya), COO of BYAH, reported beneficial ownership of 187,500 Class A Ordinary Shares, held directly. This figure reflects adjustments for a 1-for-8 reverse stock split completed on August 6, 2026.

How many Park Ha Biological (BYAH) shares does the COO hold after the reported event?

After the reported event, the COO holds 187,500 Class A Ordinary Shares of Park Ha Biological directly. The amount has been adjusted to account for a 1-for-8 reverse stock split that occurred on August 6, 2026.

Were BYAH COO Wang Li’s holdings acquired under a compensation plan?

Yes. The reported Class A Ordinary Shares held by BYAH COO Wang Li were purchased from Park Ha Biological under its 2026 Share Incentive Plan, as disclosed in the footnotes accompanying the ownership table.

How did the 1-for-8 reverse stock split affect BYAH COO’s reported shares?

Park Ha Biological effected a 1-for-8 reverse stock split on August 6, 2026. The 187,500 shares reported for the COO are already adjusted to reflect this reverse split, according to the filing footnote.

Does the BYAH Form 3 show any recent buy or sell transactions by the COO?

No specific buy or sell transaction is detailed; the Form 3 presents holdings, not trade activity. It states that the COO directly owns 187,500 Class A Ordinary Shares, adjusted for the reverse stock split.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 04:45 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Li (Alya)

(Last) (First) (Middle)

82-502 JINKE WORLD CITY

LIANGXI DISTRICT

(Street)

WUXI JIANGSU PROVINCE 214000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/03/2026

3. Issuer Name and Ticker or Trading Symbol
Park Ha Biological Technology Co., Ltd. [ BYAH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	187,500(1)(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Purchase of Class A ordinary shares from Park Ha Biological Technology Co., Ltd. pursuant to its 2026 Share Incentive Plan.

2. On August 6, 2026, Park Ha Biological Technology Co., Ltd. effected a 1-for-8 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

	/s/ Wang Li	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)